Working with the state and territory governments, we will reduce red tape and end duplication, making it easier to conduct clinical trials in Australia.
This will mean Australian patients will have greater access to the world’s best medical breakthroughs.
Today at the global biotechnology and innovation convention in Boston, United States, I reaffirmed Australia’s commitment to be the world’s best destination for clinical trials.
We are providing $7 million to support states and territories to redesign their trial systems to make it easier for researchers and companies to conduct clinical trials.
This will ultimately mean Australian patients get first access to the best medicines, devices and treatments in the world.
The concept will be informed by a review of the clinical trial registry system in Australia.
Our commitment to clinical trials is rock-solid and it builds on our unprecedented investment in health and medical research.
We recently launched a national awareness campaign to get to get more Australians into ground-breaking clinical trials, opening up access to life-saving new medicines and treatments.
The Turnbull Government recently announced a $248 million investment to support clinical trials for Australian patients with rare cancers and rare diseases, and unmet need clinical trials and registries program.
In the 2018-19 Budget we announced our commitment to deliver $6 billion in record funding for Australia’s health and medical research sector, including $3.5 billion for the National Health and Medical Research Council, $2 billion in disbursements from the Medical Research Future Fund and $500 million from the Biomedical Translation Fund.
The foundation of the Government’s commitment to health and medical research is a new job boosting $1.3 billion National Health and Medical Industry Growth Plan, to improve health outcomes for hundreds of thousands of Australians, create tens of thousands of new jobs, and develop the next generation of Australia’s global leading industries.